---
figid: PMC10380707__ijms-24-11478-g002
figtitle: Inflammation, Dopaminergic Brain and Bilirubin
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC10380707
filename: ijms-24-11478-g002.jpg
figlink: /pmc/articles/PMC10380707/figure/ijms-24-11478-f002/
number: F2
caption: 'Dopamine and bilirubin metabolism, biological effects, and shared signaling
  pathway. (a) Cartoon showing dopamine (left) and bilirubin (right) metabolism. (b)
  Cartoon resuming the principal effectors of DA dysregulation in neuropsychiatric
  and neurodegenerative conditions described in this paper (left), and the potential
  beneficial effects of YPS based both on clinic and experimental information (right),
  and the main signaling pathway shared between the neurologic conditions and YPs
  (middle). ↑: increase; ↓: decrease; TH: tyrosine hydroxylase; L-DOPA: L-dihydroxyphenylalanine;
  DA: dopamine; MAO: monoamine oxidase; DOPAL: 3,4-dihydroxyphenylacetaldehyde; ALDH:
  aldehyde dehydrogenases; DOPAC: 3,4-dihydroxyphenylacetic acid; COMT: catechol-o-methyltransferase;
  HVA: homovanilic acid. Heme: hemoglobin; HMOX: heme oxygenase; BV: biliverdin; BLVR:
  biliverdin reductase; UCB: unconjugated bilirubin («bilirubin»); UGT1a1: uridine-glucuronosyl
  transferase 1a1; CB: conjugated bilirubin; ROS: reactive oxygen species; noOS: unreactive
  oxygen species; PD: Parkinson’s disease; NOS: nitrogen reactive species; COX2: cyclooxygenase
  2; CXCL12: C-X-C motif chemokine ligand 12; TNF: tumor necrosis factor; IL: interleukin;
  TLR4: Toll-Like Receptor 4; MAPK: mitogen-activated protein kinase; NFkβ: Nuclear
  factor NF-kappa-B; RE: responsive elements; TNF-R1: tumor necrosis factor receptor
  1; ADHD: attention deficit hyperactivity disorder; ASD: autism spectrum disorder;
  IFN: interferon; Dp: depression; PPAR: peroxisome proliferator-activated receptors;
  Add: addiction; DR5: dopamine receptor 5; MS: multiple sclerosis; Sch: schizophrenia;
  EAE: experimental autoimmune encephalomyelitis (model of MS. multiple sclerosis).'
papertitle: Inflammation, Dopaminergic Brain and Bilirubin.
reftext: Sri Jayanti, et al. Int J Mol Sci. 2023 Jul;24(14):11478.
year: '2023'
doi: 10.3390/ijms241411478
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: addiction | cognition | depression | schizophrenia | Parkinson’s disease
  | attention deficit hyperactivity disorder | tumor necrosis factor | PPARs | NFkβ
  | MAPKs
automl_pathway: 0.765251
figid_alias: PMC10380707__F2
figtype: Figure
redirect_from: /figures/PMC10380707__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10380707__ijms-24-11478-g002.html
  '@type': Dataset
  description: 'Dopamine and bilirubin metabolism, biological effects, and shared
    signaling pathway. (a) Cartoon showing dopamine (left) and bilirubin (right) metabolism.
    (b) Cartoon resuming the principal effectors of DA dysregulation in neuropsychiatric
    and neurodegenerative conditions described in this paper (left), and the potential
    beneficial effects of YPS based both on clinic and experimental information (right),
    and the main signaling pathway shared between the neurologic conditions and YPs
    (middle). ↑: increase; ↓: decrease; TH: tyrosine hydroxylase; L-DOPA: L-dihydroxyphenylalanine;
    DA: dopamine; MAO: monoamine oxidase; DOPAL: 3,4-dihydroxyphenylacetaldehyde;
    ALDH: aldehyde dehydrogenases; DOPAC: 3,4-dihydroxyphenylacetic acid; COMT: catechol-o-methyltransferase;
    HVA: homovanilic acid. Heme: hemoglobin; HMOX: heme oxygenase; BV: biliverdin;
    BLVR: biliverdin reductase; UCB: unconjugated bilirubin («bilirubin»); UGT1a1:
    uridine-glucuronosyl transferase 1a1; CB: conjugated bilirubin; ROS: reactive
    oxygen species; noOS: unreactive oxygen species; PD: Parkinson’s disease; NOS:
    nitrogen reactive species; COX2: cyclooxygenase 2; CXCL12: C-X-C motif chemokine
    ligand 12; TNF: tumor necrosis factor; IL: interleukin; TLR4: Toll-Like Receptor
    4; MAPK: mitogen-activated protein kinase; NFkβ: Nuclear factor NF-kappa-B; RE:
    responsive elements; TNF-R1: tumor necrosis factor receptor 1; ADHD: attention
    deficit hyperactivity disorder; ASD: autism spectrum disorder; IFN: interferon;
    Dp: depression; PPAR: peroxisome proliferator-activated receptors; Add: addiction;
    DR5: dopamine receptor 5; MS: multiple sclerosis; Sch: schizophrenia; EAE: experimental
    autoimmune encephalomyelitis (model of MS. multiple sclerosis).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - da
  - nAChRalpha2
  - mid
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Vmat
  - DAT
  - speck
  - COX2
  - JIL-1
  - egr
  - Low
  - Dp
  - Nos
  - nos
  - hts
  - pd
  - MKP-4
  - p38b
  - rl
  - Toll-4
  - Dif
  - dl
  - Rel
  - 18w
  - tok
  - tlr-2
  - Ms
  - sch
  - Is
  - Dop1R2
  - NC2beta
  - Dop1R1
  - Pka-R1
  - retn
  - Aldh
  - Aldh-III
  - comt
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-C2
  - CrebB
  - CrebA
  - mirr
  - Keap1
  - cnc
  - BI-1
  - IRSp53
  - IleRS
  - chico
  - Cat
  - Ca-alpha1T
  - ChAT
  - sv
  - GstS1
  - GstE12
  - GstD1
  - GstD2
  - GstD3
  - GstD4
  - GstD5
  - GstD6
  - GstD7
  - GstD8
  - so
  - Sod2
  - Sod1
  - bv
  - Itgbn
  - cb
  - yps
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - N-b
  - ali
  - alpha-Est7
  - SLC6A3
  - PTGS2
  - MTCO2P12
  - IFNA1
  - IL1A
  - IL1B
  - TNFRSF1A
  - TNF
  - NOS1
  - NOS2
  - NOS3
  - IL6
  - CXCL12
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TLR4
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - TLR1
  - TLR2
  - TLR3
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - ARSD
  - TNFRSF10B
  - MS
  - IL13
  - NF2
  - HMOX1
  - DR1
  - TH
  - ALDH1A1
  - ALDH1A2
  - ALDH1A3
  - ALDH2
  - ALDH3A1
  - ALDH3A2
  - ALDH3B1
  - ALDH5A1
  - ALDH7A1
  - ALDH9A1
  - COMT
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - GABPA
  - NFE2L2
  - TMBIM6
  - NR1I2
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - CAT
  - CRAT
  - GLYAT
  - SLCO6A1
  - GSTK1
  - GSTA1
  - GSTA2
  - GSTA3
  - GSTA4
  - GSTA5
  - GSTM1
  - GSTM2
  - GSTM3
  - GSTM4
  - GSTM5
  - GSTO1
  - GSTO2
  - GSTP1
  - GSTT1
  - GSTT2
  - GSTZ1
  - GSTT2B
  - SOD1
  - SOD2
  - SOD3
  - CXCL10
  - CXCL11
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - UGT1A1
  - UGT1A10
  - UGT1A8
  - UGT1A7
  - UGT1A6
  - UGT1A4
  - BLVRA
  - BLVRB
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BCR
---
